Ameloblastoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ameloblastoma}} | |||
{{CMG}}{{AE}}{{Simrat}} | {{CMG}}; {{AE}} {{Simrat}} | ||
==Overview== | ==Overview== | ||
Secondary prevention strategies following ameloblastoma include follow-up examination at regular intervals for at least 10 years. | Secondary prevention strategies following ameloblastoma include follow-up examination at regular intervals for at least 10 years. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*Regular follow-up examination with the physician is very important in managing [[ameloblastoma]]. | *Regular follow-up examination with the physician is very important in managing [[ameloblastoma]]. | ||
*For [[ameloblastoma]] patients follow up should occur at regular intervals for at least 10 years. | *For [[ameloblastoma]] patients follow up should occur at regular intervals for at least 10 years. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 14:44, 31 May 2019
|
Ameloblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ameloblastoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Ameloblastoma secondary prevention |
|
Risk calculators and risk factors for Ameloblastoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Secondary prevention strategies following ameloblastoma include follow-up examination at regular intervals for at least 10 years.
Secondary Prevention
- Regular follow-up examination with the physician is very important in managing ameloblastoma.
- For ameloblastoma patients follow up should occur at regular intervals for at least 10 years.